Abstract
Hepatitis C virus (HCV) infection is associated with substantial clinical and economic burden and is an important public health issue in Asia. The objective of this review was to characterize HCV epidemiology and related complications in China, Japan, South Korea and Taiwan. A search of electronic databases and conference abstracts identified 71 potentially relevant articles. Of those, 55 were included in the epidemiology review and 9 in the review of HCV-related complications. HCV prevalence in the general population was 1.6 % in China, 0.6–0.9 % in Japan, 0.6–1.1 % in South Korea and 1.8–5.5 % in Taiwan. Prevalence was higher for injecting drug users (48–90 %) and those with human immunodeficiency virus coinfection (32–85 %) and was lower for blood donors (<1 %). Annual incidence of HCV in China was 6.01 per 100,000. HCV genotype 1b was associated with the highest incidence of hepatocellular carcinoma (HCC). Five-year survival for patients with liver cirrhosis was 73.8 %, decreasing to 39.2 % following liver transplantation; the majority of deaths were attributable to HCC. Limitations were that the majority of studies included in the epidemiology review were small, regional studies conducted in specific populations, and there was an absence of large population-based studies. Thus, estimates may not be representative of the epidemiology of HCV for each country. The prevalence HCV in China and HCV incidence in the Asian region remain largely unknown, and they are likely underestimated. Further epidemiologic and clinical data are needed to provide more precise estimates for use by public health agencies.
Similar content being viewed by others
References
Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001;345:41–52
Hanafiah KM, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatol 2013;57:1333–1342
Sievert W, Altraif I, Razavi HA, et al. A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver Int 2011;31:61–80
Yan Z, Fan K, Wang Y, et al. Changing pattern of clinical epidemiology on hepatitis C virus infection in Southwest China. Hepat Mon 2012;12:196–204
Hu Y, Yu C, Chen B, Wang L. Implication of reported viral hepatitis incidence rate change in Hubei Province, China, between 2004–2010. J Huazhong Univ Sci Technol 2012;32:428–433
Global Burden of Hepatitis C Working Group. J Clin Pharmacol 2004;44:20–29
Li D, Long Y, Wang T, et al. Epidemiology of hepatitis C virus infection in highly endemic HBV areas in China. PLoS ONE 2013;8:1–6
Lu W-P, Lin G-X, Shi S, Dong J-H. Simultaneously high prevalences of hepatitis B and C virus infections in a population in Putian County, China. J Clin Microbiol 2012;50:2142–2144
Katayama K, Matsuo J, Akita T, et al. Report of questionnaire survey about the rate of having hepatitis screening and the prevalence of hepatitis virus infection among the general population and the working population. Kanzo 2012;53:707–720
Miyazaki T, Honda A, Ikegami T, et al. Hepatitis C virus infection causes hypolipidemia regardless of hepatic damage or nutritional state: an epidemiological survey of a large Japanese cohort. Hepatol Res 2011;41:530–541
Kim DY, Kim IH, Jeong S-H, et al. A nationwide seroepidemiology of hepatitis C virus infection in South Korea. Liver Int 2013;33:586–594
Chung SD, Keller JJ, Liang YC, Lin HC. Association between viral hepatitis and erectile dysfunction: a population-based case-control analysis. J Sex Med 2012;9:1295–1302
Lee M-H, Yang H-I, Jen C-L, et al. Community and personal risk factors for hepatitis C virus infection: a survey of 23 820 residents in Taiwan in 1991–1992. Gut 2011;60:688–694
Wu S, Wu F, Hong R, He J. Incidence analyses and space-time cluster detection of hepatitis C in Fujian Province of China from 2006 to 2010. PLoS ONE 2012;7:1–7
Dong R, Qiao X, Jia W, et al. HIV, HCV, and HBV co-infections in a rural area of Shanxi Province with a history of commercial blood donation. Biomed Environ Sci 2011;24:207–213
Tanaka J, Koyama T, Mizui M, et al. Total numbers of undiagnosed carriers of hepatitis C and B viruses in Japan estimated by age- and area-specific prevalence on the national scale. Intervirol 2011;54:185–195
Yuan J, Yang Y, Han F, et al. Quality control measures for lowering the seroconversion rate of hemodialysis patients with hepatitis B or C virus. Hepatobiliary Pancreat Dis Int 2012;11:302–306
Wang X, Norris JL, Liu Y, et al. Health-related attitudes and risk factors for sexually transmitted infections of Chinese women who have sex with women. Chin Med J 2012;125:2819–2825
Fu Y, Qin W, Cao H, et al. HCV 6a prevalence in Guangdong province had the origin from Vietnam and recent dissemination to other regions of China: phylogeographic analyses. PLoS ONE 2012;7:1–11
Wu N, Ge Q, Feng Q, et al. High prevalence of Hepatitis C virus among injection drug users in Zhenjiang, Jiangsu, China. Indian J Virol 2011;22:77–83
Du J, Wang Z, Xie B, Zhao M. Hepatitis C knowledge and alcohol consumption among patients receiving methadone maintenance treatment in Shanghai. China. Am J Drug Alcohol Abuse 2012;38:228–232
Wang X, Tan L, Li Y, et al. HCV and HIV infection among heroin addicts in methadone maintenance treatment (MMT) and not in MMT in Changsha and Wuhan, China. PLoS ONE 2012;7:1–5
Hser Y, Du J, Li J, et al. Hepatitis C among methadone maintenance treatment patients in Shanghai and Kunming, China. J Public Health 2012;34:24–31
He N, Chen L, Lin HJ, et al. Multiple viral coinfections among HIV/AIDS patients in China. Biosci Trend 2011;5:1–9
Yan YX, Gao YQ, Sun X, et al. Prevalence of hepatitis C virus and hepatitis B virus infections in HIV-positive Chinese patients. Epidemiol Infect 2011;139:354–360
Pan X, Zhu Y, Wang Q, et al. Prevalence of HIV, syphilis, HCV and their high risk behaviours among migrant workers in Eastern China. PLoS ONE 2013;8:1–9
Yan J, Kanda T, Wu S, et al. Hepatitis A, B, C and E virus markers in Chinese residing in Tokyo, Japan. Hepatol Res 2012;42:974–981
Nagao Y, Sata M. A retrospective case-control study of hepatitis C virus infection and oral lichen planus in Japan: association study with mutations in the core and NS5A region of hepatitis C virus. BMC Gastroenterol 2012;12:1–8
Min J-A, Yoon Y, Lee HJ, et al. Prevalence and associated clinical characteristics of hepatitis B, C, and HIV infections among injecting drug users in Korea. J Med Virol 2013;85:575–582
Kang J, Cho JH, Suh CW, et al. High prevalence of hepatitis B and hepatitis C virus infections in Korean patients with hematopoietic malignancies. Ann Hematol 2011;90:159–164
Tseng Y-T, Sun H-Y, Chang S-Y, et al. Seroprevalence of hepatitis virus infection in men who have sex with men aged 18–40 years in Taiwan. J Formos Med Assoc 2012;111:431–438
Liao K-F, Lai S-W, Lin C-Y, et al. Diversity of hepatitis C virus genotypes among intravenous heroin users in Taiwan. Am J Med Sci 2011;341:110–112
Hung C-C, Loh E-W, Hu T-M, et al. Prevalence of hepatitis B and hepatitis C in patients with chronic schizophrenia living in institutions. J Chin Med Assoc 2012;75:275–280
Yu S-C, Lin C-W. Early-stage splenic diffuse large B-cell lymphoma is highly associated with hepatitis C virus infection. Kaohsiung J Med Sci 2013;29:150–156
Rao H, Wei L, Lopez-Talavera JC, et al. Distribution and clinical correlates of viral and host genotypes in Chinese patients with chronic hepatitis C virus infection. J Gastroenterol Hepatol 2014;29:545–553
Wang C, Cai WP, Tucker J, et al. Hepatitis C Epidemiology in HCV Mono-infected and HIV/HCV Co-infected Subjects from Guangzhou, China. In 1st Asian conference on hepatitis B and C, HIV and influenza, 18–19 May, Beijing, China 2012
Wang C. Epidemiology of HCV and HIV/HCV Infection in Guangzhou, China. Presentation, University of North Carolina at Chapel Hill 2013
Lee MH, Yang HI, Lu SN, et al. Hepatitis C virus genotype 1b increases cumulative lifetime risk of hepatocellular carcinoma. Int J Cancer 2014;135:1119–1126
Yatsuji S, Hashimoto E, Tobari M, et al. Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C. J Gastroenterol Hepatol 2009;24:248–254
Kim ET, Kim LH, Lee JI, Chin HS. Retinopathy in hepatitis C patients due to combination therapy with pegylated interferon and ribavirin. Jpn J Ophthalmol 2009;53:598–602
Huang JF, Chuang WL, Yu ML, et al. Hepatitis C virus infection and metabolic syndrome—a community-based study in an endemic area of Taiwan. Kaohsiung J Med Sci 2009;25:299–305
Yotsuyanagi H, Kikuchi Y, Tsukada K, et al. Chronic hepatitis C in patients co-infected with human immunodeficiency virus in Japan: a retrospective multicenter analysis. Hepatol Res 2009;39:657–663
Lee M-H, Yang H-I, Chen C-J, et al. Long-term health outcomes of chronic hepatitis C patients: a review of findings from REVEAL-HCV cohort study. BioMed (Netherlands) 2012;2(3):99–107
Hu Z, Zhou J, Wang H, et al. Survival in liver transplant recipients with hepatitis B- or hepatitis C-associated hepatocellular carcinoma: the Chinese experience from 1999 to 2010. PLoS ONE 2013;8:e61620
Qin Q, Smith MK, Wang L, et al. Hepatitis C virus infection in China: an emerging public health issue. J Viral Hepat 2015;22(3):238–244
World Health Organization, Guidelines Development Group. Guidelines for the Screening, Care and Treatment of Persons with Hepatitis C Infection. World Health Organization 2014 Accessed: 2014 Aug 20; Available at: http://www.who.int/hiv/pub/hepatitis/hepatitis-c-guidelines/en/
Lee MH, Yang HI, Yuan Y, et al. Epidemiology and natural history of hepatitis C virus infection. World J Gastroenterol 2014;20:9270–9280
Shin A, Cho ER, Kim J, et al. Factors associated with awareness of infection status among chronic hepatitis B and C carriers in Korea. Cancer Epidemiol Biomarkers Prev 2009;18:1894–1898
Acknowledgements
This research was funded by Bristol-Myers Squibb, Princeton, NJ, USA.
Compliance with ethical requirements and Conflict of interest
Heather Bennett, Nathalie Waser, Karissa Johnston, Jia-Horng Kao, Young-Suk Lim, Zhong-Ping Duan, Youn-Jae Lee, Lai Wei, Chien-Jen Chen, William Sievert, Yong Yuan and Hong Li declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bennett, H., Waser, N., Johnston, K. et al. A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan. Hepatol Int 9, 378–390 (2015). https://doi.org/10.1007/s12072-015-9629-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12072-015-9629-x